Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Genes|March 6, 2021
miR-34a and miR-200c Have an Additive Tumor-Suppressive Effect on Breast Cancer Cells and Patient PrognosisBehzad Mansoori, Nicola Silvestris, Ali Mohammadi, et al.
Clinical Nutrition (Edinburgh, Scotland)|April 12, 2022
Immunomodulatory and clinical responses to zinc gluconate supplementation in patients with Behçet's disease: A double-blind, randomized placebo-controlled clinical trialAmir Hossein Faghfouri, Alireza Khabbazi, Behzad Baradaran, et al.
International Immunopharmacology|April 20, 2023
STA-21, a small molecule STAT3 inhibitor, ameliorates experimental autoimmune encephalomyelitis by altering Th-17/Treg balanceTohid Gharibi, Nesa Barpour, Arezoo Hosseini, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|December 4, 2021
Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro studyElham Baghbani, Saeed Noorolyai, Shima Rahmani, et al.
Advanced Pharmaceutical Bulletin|April 8, 2024
The Simultaneous Effects of miR-145-5p and hsa-let-7a-3p on Colorectal Tumorigenesis: In Vitro EvidenceNazila Mozammel, Elham Baghbani, Mohammad Amini, et al.
Human Immunology|April 3, 2024
Everolimus treatment enhances inhibitory immune checkpoint molecules' expression in monocyte-derived dendritic cellsBahar Naseri, Amirhossein Mardi, Arezou Khosrojerdi, et al.
Journal of Cellular Biochemistry|December 12, 2018
Downregulation of miR-146a promotes cell migration in Helicobacter pylori-negative gastric cancerNavid Shomali, Naghmeh Shirafkan, Pascal H G Duijf, et al.
Medical Oncology (Northwood, London, England)|November 11, 2021
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancerNarges Dastmalchi, Shirin Azarbarzin, Reza Safaralizadeh, et al.
Pageof 6